Copyright
©The Author(s) 2025.
World J Psychiatry. May 19, 2025; 15(5): 103256
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.103256
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.103256
Figure 1 Flow diagram of the trial.
HOA: Healthy old adults; MCI: Mild cognitive impairment; MBI: Mild behavioral impairment; M: Male; F: Female.
Figure 2 Comparison of plasma biomarkers between mild cognitive impairment groups with or without mild behavioral impairment.
The sample size for mild cognitive impairment (MCI) + mild behavioral impairment (MBI) - was 89, and 16 for MCI + MBI +. aP < 0.05. Significance star for independent sample t-test. MCI: Mild cognitive impairment; MBI: Mild behavioral impairment; p-tau217: Hyperphosphorylated tau; Aβ: Amyloid β.
- Citation: Liang W, Wang L, Song M, Geng H, Jing XY, Li W, Huo YX, Huang AQ, Wang XY, An CX. Correlation between mild behavioral impairment and peripheral blood biomarkers in patients with mild cognitive impairment. World J Psychiatry 2025; 15(5): 103256
- URL: https://www.wjgnet.com/2220-3206/full/v15/i5/103256.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i5.103256